oleanolic acid has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreeff, M; Beran, M; Dunner, K; Kantarjian, H; Kondo, S; Konopleva, M; Korchin, B; Kurinna, S; Ruvolo, P; Samudio, I | 1 |
1 other study(ies) available for oleanolic acid and imatinib mesylate
Article | Year |
---|---|
Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Dose-Response Relationship, Drug; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitochondria; Oleanolic Acid; Oxidation-Reduction; Oxygen; Piperazines; Pyrimidines; Reactive Oxygen Species | 2008 |